Oliver Sartor Selected Research

Castration

7/2022	Embracing the Practical Aspects of Theranostics With Prostate-Specific Membrane Antigen-Targeted Lutetium-177.
1/2022	Real-world outcomes of second novel hormonal therapy or radium-223 following first novel hormonal therapy for mCRPC.
1/2022	Real-world patient characteristics associated with survival of 2 years or more after radium-223 treatment for metastatic castration-resistant prostate cancer (EPIX study).
1/2022	The impact of genetic aberrations on response to radium-223 treatment for castration-resistant prostate cancer with bone metastases.
1/2022	Neutropenia, neutrophilia, and neutrophil-lymphocyte ratio as prognostic markers in patients with metastatic castration-resistant prostate cancer.
1/2022	177Lu-Prostate-Specific Membrane Antigen Ligand After 223Ra Treatment in Men with Bone-Metastatic Castration-Resistant Prostate Cancer: Real-World Clinical Experience.
1/2022	Prostate Cancer Treatment: 177Lu-PSMA-617 Considerations, Concepts, and Limitations.
12/2021	Efficacy of systemic therapies in men with metastatic castration resistant prostate cancer harboring germline ATM versus BRCA2 mutations.
3/2021	Pain Progression at Initiation of Cabazitaxel in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Post Hoc Analysis of the PROSELICA Study.
1/2021	TRANSFORMER: A Randomized Phase II Study Comparing Bipolar Androgen Therapy Versus Enzalutamide in Asymptomatic Men With Castration-Resistant Metastatic Prostate Cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Oliver Sartor Research Topics

Disease

222	Prostatic Neoplasms (Prostate Cancer) 11/2022 - 05/2002
66	Neoplasms (Cancer) 01/2022 - 05/2002
38	Neoplasm Metastasis (Metastasis) 01/2022 - 05/2003
15	Pain (Aches) 03/2021 - 01/2004
15	Disease Progression 01/2021 - 01/2004
9	Anemia 01/2020 - 05/2002
8	Adenocarcinoma 01/2022 - 03/2010
7	Neutropenia 01/2022 - 05/2002
6	Drug-Related Side Effects and Adverse Reactions 11/2012 - 10/2003
4	Margins of Excision 01/2020 - 08/2013
4	Thrombocytopenia (Thrombopenia) 03/2018 - 02/2007
4	Carcinogenesis 08/2011 - 11/2004
3	Breast Neoplasms (Breast Cancer) 11/2020 - 12/2010
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2020 - 12/2012
3	Progressive Multifocal Leukoencephalopathy 12/2014 - 05/2009
3	Atrophy 12/2005 - 10/2004
2	Ovarian Neoplasms (Ovarian Cancer) 11/2020 - 01/2008
2	Microsatellite Instability 01/2020 - 01/2019
2	Venous Thromboembolism 01/2020 - 11/2012
2	Infections 01/2020 - 02/2016
2	Carcinoma (Carcinomatosis) 01/2016 - 01/2005
2	Lymphoma (Lymphomas) 08/2014 - 03/2010

Drug/Important Bio-Agent (IBA)

48	AndrogensIBA 01/2021 - 05/2002
43	Prostate-Specific Antigen (Semenogelase)IBA 11/2022 - 09/2002
33	Docetaxel (Taxotere)FDA Link 01/2022 - 02/2008
29	Hormones (Hormone)IBA 11/2022 - 05/2002
27	Radium-223IBA 01/2022 - 10/2013
24	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 09/2002
20	enzalutamideIBA 12/2021 - 01/2013
18	abirateroneIBA 01/2022 - 01/2011
15	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2009
14	Pharmaceutical PreparationsIBA 01/2021 - 10/2003
13	cabazitaxel FDA Link 01/2022 - 12/2010
11	AntigensIBA 10/2022 - 08/2013
10	RadiopharmaceuticalsIBA 01/2022 - 05/2003
10	Testosterone (Sustanon)FDA Link 01/2021 - 02/2003
9	Biological ProductsIBA 03/2021 - 01/2004
9	taxaneIBA 01/2021 - 12/2010
9	Prednisone (Sone)FDA LinkGeneric 12/2020 - 11/2009
7	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 01/2020
7	Gonadotropin-Releasing Hormone (GnRH)FDA Link 08/2015 - 02/2003
6	IsotopesIBA 07/2022 - 05/2003
6	RadiumIBA 01/2022 - 12/2013
6	LigandsIBA 01/2022 - 03/2013
6	sipuleucel-T (APC8015)FDA Link 01/2022 - 10/2011
6	Hemoglobins (Hemoglobin)IBA 01/2020 - 05/2005
6	Circulating Tumor DNAIBA 01/2020 - 01/2019
5	PlatinumIBA 01/2022 - 01/2008
5	Cell-Free Nucleic AcidsIBA 01/2021 - 01/2018
5	HematinicsIBA 01/2020 - 03/2010
5	Mitoxantrone (Novantrone)FDA LinkGeneric 10/2017 - 01/2008
5	Dutasteride (Avodart)FDA Link 08/2015 - 02/2009
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 02/2008
4	olaparibIBA 01/2021 - 01/2020
4	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2021 - 01/2020
4	Androgen Antagonists (Antiandrogens)IBA 01/2020 - 10/2005
4	Alkaline PhosphataseIBA 10/2018 - 05/2005
4	Radioisotopes (Radionuclides)IBA 01/2018 - 05/2003
3	NucleotidesIBA 01/2022 - 03/2010
3	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2004
3	samarium Sm-153 lexidronam (Quadramet)FDA Link 01/2018 - 02/2007
3	bicalutamide (Casodex)FDA LinkGeneric 01/2017 - 10/2009
3	Estrogens (Estrogen)FDA Link 01/2017 - 02/2003
3	Diphosphonates (Bisphosphonates)IBA 01/2016 - 03/2006
3	Messenger RNA (mRNA)IBA 05/2015 - 05/2005
3	Leuprolide (Lupron)FDA LinkGeneric 01/2015 - 08/2003
3	Dexamethasone (Maxidex)FDA LinkGeneric 09/2014 - 05/2010
3	SaposinsIBA 12/2005 - 11/2004
2	177Lu-PSMA-617IBA 01/2022 - 01/2021
2	VaccinesIBA 01/2022 - 01/2016
2	rucaparibIBA 01/2021 - 10/2020
2	Poly Adenosine Diphosphate RiboseIBA 01/2021 - 01/2020
2	atezolizumabIBA 01/2021 - 01/2019
2	Prednisolone (Predate)FDA LinkGeneric 12/2020 - 01/2017
2	Carboplatin (JM8)FDA LinkGeneric 01/2020 - 02/2008
2	pembrolizumabIBA 01/2020 - 01/2019
2	RNA (Ribonucleic Acid)IBA 11/2019 - 02/2017
2	Abiraterone AcetateIBA 10/2019 - 02/2017
2	Samarium-153IBA 01/2018 - 05/2004
2	Analgesics (Analgesic Drugs)IBA 11/2016 - 05/2004
2	Interleukin-17 ReceptorsIBA 03/2016 - 05/2012
2	Interleukin-17 (Interleukin 17)IBA 03/2016 - 05/2012
2	Erythropoietin Receptors (Erythropoietin Receptor)IBA 01/2016 - 11/2012
2	Zoledronic Acid (Zometa)FDA Link 11/2015 - 03/2006
2	Denosumab FDA Link 11/2015 - 07/2011
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2014 - 11/2012
2	Rituximab (Mabthera)FDA Link 12/2014 - 05/2009
2	Taxoids (Taxanes)IBA 09/2014 - 06/2011

Therapy/Procedure

109	Therapeutics 10/2022 - 09/2002
106	Castration 07/2022 - 02/2003
38	Drug Therapy (Chemotherapy) 01/2022 - 10/2004
22	Radiotherapy 07/2022 - 05/2012
15	Prostatectomy (Retropubic Prostatectomy) 01/2022 - 12/2007
5	Aftercare (After-Treatment) 01/2022 - 03/2008
4	Precision Medicine 07/2022 - 01/2019
3	Immunotherapy 01/2022 - 01/2016
3	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 01/2017
3	Injections 10/2019 - 11/2014
2	Nephrectomy 01/2015 - 12/2012